1. Home
  2. ITRM vs KITT Comparison

ITRM vs KITT Comparison

Compare ITRM & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • KITT
  • Stock Information
  • Founded
  • ITRM 2015
  • KITT 2014
  • Country
  • ITRM Ireland
  • KITT United States
  • Employees
  • ITRM N/A
  • KITT N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • KITT Industrial Machinery/Components
  • Sector
  • ITRM Health Care
  • KITT Industrials
  • Exchange
  • ITRM Nasdaq
  • KITT Nasdaq
  • Market Cap
  • ITRM 40.0M
  • KITT 36.4M
  • IPO Year
  • ITRM 2018
  • KITT N/A
  • Fundamental
  • Price
  • ITRM $0.68
  • KITT $3.34
  • Analyst Decision
  • ITRM Strong Buy
  • KITT
  • Analyst Count
  • ITRM 2
  • KITT 0
  • Target Price
  • ITRM $7.00
  • KITT N/A
  • AVG Volume (30 Days)
  • ITRM 749.8K
  • KITT 407.1K
  • Earning Date
  • ITRM 11-13-2025
  • KITT 11-11-2025
  • Dividend Yield
  • ITRM N/A
  • KITT N/A
  • EPS Growth
  • ITRM N/A
  • KITT N/A
  • EPS
  • ITRM N/A
  • KITT N/A
  • Revenue
  • ITRM N/A
  • KITT $3,082,232.00
  • Revenue This Year
  • ITRM N/A
  • KITT $2,936.06
  • Revenue Next Year
  • ITRM $249.35
  • KITT N/A
  • P/E Ratio
  • ITRM N/A
  • KITT N/A
  • Revenue Growth
  • ITRM N/A
  • KITT N/A
  • 52 Week Low
  • ITRM $0.61
  • KITT $3.33
  • 52 Week High
  • ITRM $3.02
  • KITT $54.36
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 43.17
  • KITT 23.10
  • Support Level
  • ITRM $0.61
  • KITT $3.35
  • Resistance Level
  • ITRM $0.76
  • KITT $3.72
  • Average True Range (ATR)
  • ITRM 0.05
  • KITT 0.83
  • MACD
  • ITRM 0.01
  • KITT -0.34
  • Stochastic Oscillator
  • ITRM 49.65
  • KITT 0.14

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.

Share on Social Networks: